معرفی
Jonatan Lindh is a Senior Lecturer at the Department of Laboratory Medicine, Karolinska Institutet. His work focuses on Clinical Laboratory Medicine, Medical Genetics and Genomics, Pharmacology, and Toxicology. He investigates hyponatremia, drug interactions (particularly with warfarin and tamoxifen), and pharmacogenomic factors affecting treatment outcomes.
- Education
- Medical Degree, Karolinska Institutet (1998)
- PhD in Laboratory Medicine, Karolinska Institutet (2009)
- Docent (Senior Lecturer), Karolinska Institutet (2018)
His research highlights drug-induced hyponatremia, CYP enzyme polymorphisms, and vitamin D interactions. Recent studies examine the impact of climate change on hyponatremia prevalence and the role of genetic factors in anticoagulant therapy.
Key trends in publications include:
- Hyponatremia as a marker for drug safety and chronic disease
- Pharmacogenomic influences on tamoxifen and warfarin efficacy
- Epidemiological analyses of adrenal tumors and comorbidities
- Systematic reviews on vitamin D and drug metabolism
- Population-based studies on socioeconomic factors in migraine treatment
He is affiliated with the Division of Clinical Pharmacology at Labmed, conducting research in Stockholm and Huddinge, Sweden.
